This week's report explores the pharmaceutical industry’s evolution toward resilient, scalable systems that prioritize ...

USP is developing digital reference standards to integrate into modern digital environments, enhancing regulatory confidence ...

As more drugs go subcutaneous, Phillips Medisize's director of Front-End Innovation, Tony Bedford, believes that high-dose biologics will become a prevalent choice for drugmakers.

Pharma and advanced therapy manufacturing will only grow more complex in science, regulation, and global scale. But the ...

In A Nutshell Personalized AI “health agents,” virtual drug trials, and automated compliance tools could quietly speed up ...

Dr. Ravindranath Kancherla, the founder of Global Hospitals and Global HealthX reflects on how India can emerge as a global proving ground for affordable, high-impact medical innovation.

How direct-to-patient programming can transform the prescription journey for patients and manufacturers alike. The status quo ...

In the second part of his Pharma Commerce video interview, Hari Kiran Chereddi, CEO of HRV Pharma, describes how AI-driven orchestration, real-time data integration, and federated learning are ...